| Disclosure of operating segments |
| | | | | | | | | | | | | | | | | | | 12/31/2025 | | Pulp | | Paper | | Total | Net sales | 37,816,141 | | | 12,299,538 | | | 50,115,679 | | Domestic market (Brazil) | 1,786,984 | | | 7,462,804 | | | 9,249,788 | | Foreign market | 36,029,157 | | | 4,836,734 | | | 40,865,891 | | Asia | 17,987,863 | | | 45,083 | | | 18,032,946 | | Europe | 10,532,908 | | | 344,813 | | | 10,877,721 | | North America | 6,901,189 | | | 3,321,114 | | | 10,222,303 | | South America and Central | 588,451 | | | 1,069,113 | | | 1,657,564 | | Africa | 18,746 | | | 56,611 | | | 75,357 | | Cost of sales | (25,321,167) | | | (8,568,337) | | | (33,889,504) | | | | | | | | | Adjusted EBITDA | 18,891,646 | | | 2,844,674 | | | 21,736,320 | | | Adjustments to EBITDA (*) | | | | | 209,947 | | | Depreciation, depletion and amortization | | | | | (11,297,258) | | | Financial result | | | | | 9,762,165 | | Net income before taxes | | | | | 20,411,174 | |
| | | | | | | | | | | | | | | | | | | 12/31/2024 | | Pulp | | Paper | | Total | Net sales | 37,593,462 | | | 9,809,820 | | | 47,403,282 | | Domestic market (Brazil) | 2,295,258 | | | 7,278,586 | | | 9,573,844 | | Foreign market | 35,298,204 | | | 2,531,234 | | | 37,829,438 | | Asia | 15,760,800 | | | 24,767 | | | 15,785,567 | | Europe | 11,895,394 | | | 355,784 | | | 12,251,178 | | North America | 6,965,731 | | | 914,234 | | | 7,879,965 | | South America and Central | 670,157 | | | 1,179,840 | | | 1,849,997 | | Africa | 6,122 | | | 56,608 | | | 62,730 | | Cost of sales | (21,261,705) | | | (6,139,822) | | | (27,401,527) | | | | | | | | | Adjusted EBITDA | 20,866,160 | | | 2,983,040 | | | 23,849,200 | | | Adjustments to EBITDA (*) | | | | | 1,065,887 | | | Depreciation, depletion and amortization | | | | | | | (9,223,995) | | | Financial result | | | | | (28,802,145) | | Net income before taxes | | | | | | | (13,111,053) | |
| | | | | | | | | | | | | | | | | | | 12/31/2023 | | Pulp | | Paper | | Total | Net sales | 30,677,265 | | | 9,078,310 | | | 39,755,575 | | Domestic market (Brazil) | 2,144,199 | | | 6,719,093 | | | 8,863,292 | | Foreign market | 28,533,066 | | | 2,359,217 | | | 30,892,283 | | Asia | 13,588,032 | | | 72,133 | | | 13,660,165 | | Europe | 8,701,141 | | | 302,131 | | | 9,003,272 | | North America | 5,682,010 | | | 476,429 | | | 6,158,439 | | South America and Central | 558,601 | | | 1,437,181 | | | 1,995,782 | | Africa | 3,282 | | | 71,343 | | | 74,625 | | Cost of sales | (19,694,674) | | | (5,382,001) | | | (25,076,675) | | | | | | | | | Adjusted EBITDA | 15,194,660 | | | 3,078,310 | | | 18,272,970 | | | Adjustments to EBITDA (*) | | | | | 1,264,428 | | | Depreciation, depletion and amortization | | | | | (7,321,110) | | | Financial result | | | | | 5,780,928 | | Net income before taxes | | | | | 17,997,216 | |
| | | | | | | | | | | | | | | | | | | | | | | 12/31/2025 | | 12/31/2024 | | 12/31/2023 | | (*) Adjustments to EBITDA | | | | | | | Fair Value - Biological Asset | | 1,516,458 | | | 1,431,530 | | | 1,989,831 | | Loss from associates and joint ventures (2) (3) | | (409,212) | | | (13,845) | | | (19,379) | | Impairment of subsidiaries (2) | | (88,871) | | | | | | Income from disposal and write-off of non-current assets | | (386,396) | | | (169,284) | | | (232,143) | | Provision/(reversals) for losses on ICMS credits (note 9.1) | | (193,152) | | | (130,726) | | | (348,628) | | Expenses on Asset Acquisition and Business Combinations | | (82,426) | | | (34,065) | | | (25,171) | | Write-off of wood inventory | | (78,203) | | | (11,930) | | | (22,998) | | Restructuring expenses | | (59,725) | | | (1,205) | | | (8,974) | | Others (1) | | (8,526) | | | (4,588) | | | (68,110) | | | | 209,947 | | | 1,065,887 | | | 1,264,428 | |
(1) It includes items with specific, non-cash and exceptional adjustments, such as: i) effective loss of the development contract advance program; ii) fines and cancellation of contracts; iii) tax credits - exclusion of ICMS from the PIS and COFINS calculation basis; and iv) donations for catastrophes and pandemics. (2) It includes the impact of the transaction with the associate Spinnova Plc involving the joint venture Woodspin Oy and the subsidiary Suzano Finland Oy (note 14.2). (3) It includes the impact of the transaction with the associate Ensyn Corporation involving the joint venture F&E Technologies LLC and the subsidiary F&E Tecnologia do Brasil S.A. (note 14.2).
|